Literature DB >> 23044311

Comparison of neonatal tolerance to thoracoscopic and open repair of esophageal atresia with tracheoesophageal fistula.

Li Ma1, Yong-Zhe Liu, Ya-Qun Ma, Sheng-Suo Zhang, Ning-Ling Pan.   

Abstract

BACKGROUND: Advances in minimally invasive surgical techniques and neonatal intensive care for neonates have allowed for repair of the neonatal esophageal atresia with tracheoesophageal fistula (EA/TEF) to be approached endoscopically. However, thoracoscopic surgery in children is still performed in only a few centers throughout the world. The aim of this study was to compare the neonatal tolerance to the thoracoscopic repair (TR) and the open repair (OR) and also to discuss anesthetic management in thoracoscopic procedure.
METHODS: We performed a prospective study enrolling newborns diagnosed with EA with distal TEF (type C) receiving the repair surgery between June 2009 and January 2012 in our institution. Data collected included the newborns' gestational age and weight at the time of the operation, operative time, parameters of intraoperative mechanical ventilation, oxygenation, end-tidal carbon dioxide (ETCO2), and analysis of blood gases. Time to extubation and length of stay were also recorded.
RESULTS: Intravenous induction with muscle paralysis followed by pressure-control ventilation and tracheal intubation regardless of the position of the fistula can be performed uneventfully in EA/TEF newborns with no additional airway anomalies and large, pericarinal fistulas in our experiences. The thoracoscopic approach appeared to take longer than the open approach. During the procedure of repair, hypercarbia and acidosis developed immediately 1 hour after pneumothorax in both groups. CO2 insufflation did have additional influence on the respiratory function of the newborns in the TR group; values of PaCO2 and ETCO2 were higher in the TR group but the difference did not reach statistical significance. By the end of the procedure, values of PaCO2 and ETCO2 returned to the baseline levels while pH did not, but all parameters made no difference in the two groups. Besides, time to extubation was shorter in the TR group.
CONCLUSIONS: Thoracoscopic repair of EA/TEF is comparable to the open repair, and is believed to be safe and tolerable in selected patients. A wider range of neonates may be acceptable for thoracoscopic EA/TEF repair with increasing surgical experience.

Entities:  

Mesh:

Year:  2012        PMID: 23044311

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  5 in total

Review 1.  Comparison of clinical outcomes between open and thoracoscopic repair for esophageal atresia with tracheoesophageal fistula: a systematic review and meta-analysis.

Authors:  Yuhao Wu; Hongyu Kuang; Tiewei Lv; Chun Wu
Journal:  Pediatr Surg Int       Date:  2017-09-15       Impact factor: 1.827

2.  Thoracoscopy vs. thoracotomy for the repair of esophageal atresia and tracheoesophageal fistula: a systematic review and meta-analysis.

Authors:  Colin Way; Carolyn Wayne; Viviane Grandpierre; Brittany J Harrison; Nicole Travis; Ahmed Nasr
Journal:  Pediatr Surg Int       Date:  2019-07-29       Impact factor: 1.827

3.  Management of patients with combined tracheoesophageal fistula, esophageal atresia, and duodenal atresia.

Authors:  Christoph S Nabzdyk; Bill Chiu; Carl-Christian Jackson; Walter J Chwals
Journal:  Int J Surg Case Rep       Date:  2014-11-06

Review 4.  Outcomes of thoracoscopy versus thoracotomy for esophageal atresia with tracheoesophageal fistula repair: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Yi-Fan Yang; Rui Dong; Chao Zheng; Zhu Jin; Gong Chen; Yan-Lei Huang; Shan Zheng
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

5.  Surgical management of newborns with combined tracheoesophageal fistula, esophageal atresia, and duodenal obstruction.

Authors:  Zhu-Ping Cao; Qi-Feng Li; Shi-Qi Liu; Jian-Hua Niu; Jing-Ru Zhao; Ya-Jun Chen; Da-Yong Wang; Xiao-Song Li
Journal:  Chin Med J (Engl)       Date:  2019-03-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.